Transcranial Direct Current Stimulation Beneficial in Alzheimer Disease
By Elana Gotkine HealthDay Reporter
THURSDAY, Dec. 7, 2023 -- For patients with Alzheimer disease (AD), active transcranial direct current stimulation (tDCS) may improve cognitive function, according to a study published online Dec. 5 in General Psychiatry.
Xingxing Li, from the Ningbo Kangning Hospital & Affiliated Mental Health Centre at Ningbo University in China, and colleagues examined the role of tDCS in improving cognition among patients with AD. One hundred twenty-four patients were randomly assigned to active tDCS or sham tDCS (63 and 61 patients, respectively), applied at the dorsolateral prefrontal cortex for 30 treatment sessions across six weeks.
The researchers found that multiple courses of tDCS improved the cognitive functions of patients with AD, especially word recall, recall of test instructions, and word recognition in the memory domain. Following active treatment, there was enhancement in the damaged motor-evoked potential (MEP) level. Negative correlations were seen for improvements in the Alzheimer's Disease Assessment Scale-Cognitive total and subitem (word recall and word recognition) scores with the enhancement of MEP in the active tDCS group.
"The results of this study strongly indicate that tDCS treatment is a significant and promising intervention for improving cognitive function in AD," the authors write. "Further research is needed to elucidate the relationship between plasticity and cognition."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-08 02:15
Read more
- Electronic Sepsis Screening Reduces 90-Day In-Hospital Mortality
- Data Suggests TNF Inhibitors Help Prevent Serious Complications in Children with Crohn's Disease
- LimmaTech Awarded FDA Fast Track Designation for Vaccine Candidate Against Staphylococcus aureus
- Sumitomo Pharma America Announces U.S. FDA Approval of Gemtesa (vibegron) for Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia
- Airport and Aircraft Noise Can Hurt Your Heart
- FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions